IAS Divya Mittal has cleared some of the toughest entrance examinations in the country, including those for IIT, IIM, and UPSC. She admitted that she too faced distractions during her studies but ...
Just one dose of psilocybin combined with therapy is associated with “significantly increased long-term abstinence” from cigarettes compared to nicotine patches, according to a new study published by ...
Discover an effective UPSC PYQ-based study strategy to boost your preparation. Learn how to analyze previous year questions, identify trends, and improve accuracy for UPSC Prelims.
House dust mite sublingual immunotherapy reduces symptoms, decreases medication use, and shows a favorable safety profile in ...
Although one GLP-1 study made national headlines about the drug class’ potential use in addiction treatment, other research indicates GLP-1s could increase the risk of bone injuries and are less ...
3don MSN
Study: Students spend a third of their school day on their phones, without strong cellphone policy
A new study from researchers at the University of North Carolina at Chapel Hill offers insight for schools trying to curb ...
Payments that enable landowners to rewild ecologically degraded land—in the form of biodiversity credits bought by investors ...
Psilocybin, also known as “magic mushrooms,” may help smokers quit tobacco for the long term. Smokers who received psilocybin alongside CBT counseling were six times more likely to quit than those ...
Newspoint on MSN
Study suggests protein in egg whites may provide scalable, effective solution against forever chemicals
New Delhi | A study has found that ovalbumin, the primary protein in egg whites, could effectively bind and remove per- and polyfluoroalkyl substances from contaminated water, offering a scalable ...
A new study, published in JAMA Network Open, reports the outcome of a clinical trial out of Johns Hopkins University assessing the effectiveness of psilocybin as a treatment for smokers attempting to ...
Vertex Pharmaceuticals (VRTX) announced data from a Phase 4 study of JOURNAVX, a prescription non-opioid pain signal inhibitor for the treatment of moderate-to-severe acute pain, in adults, that ...
There are multiple factors that have an impact.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results